Merck KGaA (OTCMKTS:MKKGY) Stock Rated “Hold” by Sell-Side Brokerages

Merck KGaA (OTCMKTS:MKKGY) has received a consensus recommendation of “Hold” from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation.

A number of research firms have recently commented on MKKGY. Zacks Research downgraded Merck KGaA from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 20th. UBS Group cut shares of Merck KGaA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 20th. Finally, HSBC raised shares of Merck KGaA to a “hold” rating in a research report on Monday, July 6th.

Merck KGaA Price Performance

MKKGY opened at $31.66 on Tuesday. Merck KGaA has a 1 year low of $23.73 and a 1 year high of $34.19. The company’s 50 day simple moving average is $31.83 and its 200 day simple moving average is $29.75. The stock has a market capitalization of $20.46 billion, a PE ratio of 16.32, a P/E/G ratio of 2.92 and a beta of 0.96. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.09 and a current ratio of 1.69.

About Merck KGaA

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest pharmaceutical and chemical businesses. Merck KGaA operates independently from the U.S.-based Merck & Co, Inc, which uses the name MSD in markets outside the United States and Canada.

The company operates through three primary business sectors: Life Science, Healthcare and Electronics. Its Life Science business supplies laboratory products, research tools, bioprocessing equipment and services used by academic institutions, pharmaceutical manufacturers and other industrial customers.